PRINTER'S NO. 752
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No.
683
Session of
2023
INTRODUCED BY MASTRIANO, BROOKS AND BARTOLOTTA, MAY 15, 2023
REFERRED TO HEALTH AND HUMAN SERVICES, MAY 15, 2023
AN ACT
Amending Title 35 (Health and Safety) of the Pennsylvania
Consolidated Statutes, in public safety, providing for
miscellaneous provisions.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Title 35 of the Pennsylvania Consolidated
Statutes is amended by adding a chapter to read:
CHAPTER 59
MISCELLANEOUS PROVISIONS
Sec.
5901. (Reserved).
5902. Urine drug screening requirement.
§ 5901. (Reserved).
§ 5902. Urine drug screening requirement.
(a) General rule.--If a urine drug screening is conducted in
a general acute care hospital to assist in diagnosing a
patient's condition, the urine drug screening shall include
testing for fentanyl.
(b) Reporting.--If the urine drug screening conducted in
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
accordance with subsection (a) detects fentanyl, the hospital
shall report the test results, which shall be deidentified, to
the Department of Health through PA-NEDSS.
(c) Construction.--Nothing in this section shall preclude an
acute care hospital without analyzer equipment for urinalysis
from utilizing fentanyl test strips in accordance with the act
of April 14, 1972 (P.L.233, No.64), known as The Controlled
Substance, Drug, Device and Cosmetic Act.
(d) Definitions.--As used in this section, the following
words and phrases shall have the meanings given to them in this
subsection unless the context clearly indicates otherwise:
"Acute care hospital." A facility that provides inpatient
and outpatient hospital services and is licensed by the
Department of Health as a general or tertiary care hospital. The
term does not include a specialty hospital.
"Controlled substance." A drug, substance or immediate
precursor included in Schedules I through V of The Controlled
Substance, Drug, Device and Cosmetic Act.
"PA-NEDSS." Pennsylvania's version of the National
Electronic Disease Surveillance System.
"Urine drug screening." A chemical analysis intended to test
a patient for the presence of a controlled substance.
Section 2. This act shall take effect in 60 days.
20230SB0683PN0752 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23